Serge Belanger
Stock Analyst at Needham
(3.50)
# 919
Out of 4,712 analysts
307
Total ratings
45.64%
Success rate
5.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals | Reiterates: Hold | n/a | $0.69 | - | 16 | Dec 20, 2024 | |
| OMER Omeros | Reiterates: Hold | n/a | $10.00 | - | 4 | Dec 19, 2024 | |
| ESPR Esperion Therapeutics | Reiterates: Buy | $6 | $2.30 | +160.87% | 17 | Dec 13, 2024 | |
| TRVI Trevi Therapeutics | Reiterates: Buy | $8 | $4.00 | +100.00% | 17 | Dec 12, 2024 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $28 | $8.76 | +219.63% | 17 | Dec 5, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Buy | $36 | $25.95 | +38.73% | 5 | Dec 5, 2024 | |
| HRTX Heron Therapeutics | Reiterates: Buy | $4 | $1.58 | +153.16% | 20 | Dec 4, 2024 | |
| CYTK Cytokinetics | Reiterates: Buy | $72 | $48.53 | +48.36% | 19 | Dec 2, 2024 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $38 | $19.31 | +96.79% | 14 | Nov 25, 2024 | |
| LQDA Liquidia | Reiterates: Buy | $19 | $11.53 | +64.79% | 25 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.93 | +545.86% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $38.42 | +56.17% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $3.08 | - | 20 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $19.47 | +12.99% | 23 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $14.99 | +20.08% | 16 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $7.67 | +82.53% | 9 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $18 | $8.33 | +116.09% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $10.85 | +102.76% | 11 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $62 | $52.67 | +17.71% | 10 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $29.06 | - | 23 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $38.27 | - | 4 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.86 | - | 1 | Mar 31, 2022 |
Verrica Pharmaceuticals
Dec 20, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.69
Upside: -
Omeros
Dec 19, 2024
Reiterates: Hold
Price Target: n/a
Current: $10.00
Upside: -
Esperion Therapeutics
Dec 13, 2024
Reiterates: Buy
Price Target: $6
Current: $2.30
Upside: +160.87%
Trevi Therapeutics
Dec 12, 2024
Reiterates: Buy
Price Target: $8
Current: $4.00
Upside: +100.00%
KalVista Pharmaceuticals
Dec 5, 2024
Reiterates: Buy
Price Target: $28
Current: $8.76
Upside: +219.63%
NewAmsterdam Pharma Company
Dec 5, 2024
Reiterates: Buy
Price Target: $36
Current: $25.95
Upside: +38.73%
Heron Therapeutics
Dec 4, 2024
Reiterates: Buy
Price Target: $4
Current: $1.58
Upside: +153.16%
Cytokinetics
Dec 2, 2024
Reiterates: Buy
Price Target: $72
Current: $48.53
Upside: +48.36%
Viridian Therapeutics
Nov 25, 2024
Reiterates: Buy
Price Target: $38
Current: $19.31
Upside: +96.79%
Liquidia
Nov 14, 2024
Reiterates: Buy
Price Target: $19
Current: $11.53
Upside: +64.79%
Nov 13, 2024
Reiterates: Buy
Price Target: $6
Current: $0.93
Upside: +545.86%
Nov 13, 2024
Reiterates: Buy
Price Target: $60
Current: $38.42
Upside: +56.17%
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $3.08
Upside: -
Nov 8, 2024
Reiterates: Buy
Price Target: $22
Current: $19.47
Upside: +12.99%
Nov 7, 2024
Reiterates: Buy
Price Target: $18
Current: $14.99
Upside: +20.08%
Nov 5, 2024
Reiterates: Buy
Price Target: $14
Current: $7.67
Upside: +82.53%
Oct 31, 2024
Maintains: Buy
Price Target: $10 → $18
Current: $8.33
Upside: +116.09%
Sep 13, 2024
Reiterates: Buy
Price Target: $22
Current: $10.85
Upside: +102.76%
Sep 12, 2024
Reiterates: Buy
Price Target: $62
Current: $52.67
Upside: +17.71%
Aug 9, 2024
Reiterates: Hold
Price Target: n/a
Current: $29.06
Upside: -
Aug 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $38.27
Upside: -
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.86
Upside: -